Identifying immune responses to the SARS-CoV-2 virus
B-CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION: Modification for SARS-CoV2 Research
This study is looking at parts of the COVID-19 virus that can help our immune system fight it off, with the hope that this information will lead to better vaccines and treatments for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11169641 on NIH RePORTER |
What this research studies
This research focuses on discovering specific parts of the SARS-CoV-2 virus that can trigger an immune response in humans. By identifying these B cell epitopes, the study aims to understand how antibodies can protect against COVID-19. The approach involves mapping these epitopes to enhance our understanding of antibody-mediated immunity. Patients may benefit from insights that could lead to improved vaccines or therapies targeting COVID-19.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have been infected with SARS-CoV-2 or are at risk of COVID-19.
Not a fit: Patients who have not been exposed to SARS-CoV-2 or those with no interest in COVID-19 related research may not benefit from this study.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines and treatments for COVID-19.
How similar studies have performed: Other research has shown success in identifying B cell epitopes for various viruses, suggesting a promising approach for COVID-19.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Crowe, James E — Vanderbilt University Medical Center
- Study coordinator: Crowe, James E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.